FDA Drug Recalls

Recalls / Class II

Class IID-0158-2023

Product

Tobramycin Ophthalmic Solution, USP, 0.3%, 5 mL per bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045; Distributed by: MWI, Boise, ID 83705. NDC 13985-604-05

Affected lot / code info
Lot: 1D94A, EXP 3/31/2023; 1E35A, EXP 4/30/2023; 2A06A, EXP 12/31/2023

Why it was recalled

CGMP Deviations:

Recalling firm

Firm
Akorn, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
5605 Centerpoint Ct Ste A, N/A, Gurnee, Illinois 60031-5278

Distribution

Quantity
91,692 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-10-13
FDA classified
2023-01-13
Posted by FDA
2023-01-25
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0158-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.